Detalles de la búsqueda
1.
Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors.
Bioorg Med Chem
; 90: 117367, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348260
2.
In silico screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agents.
J Recept Signal Transduct Res
; 42(6): 549-561, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704515
3.
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition.
Mol Divers
; 26(3): 1411-1423, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247323
4.
Dual potent c-Met and ALK inhibitors: from common feature pharmacophore modeling to structure based virtual screening.
J Recept Signal Transduct Res
; 40(4): 357-364, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32126881
5.
Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprints.
J Recept Signal Transduct Res
; 39(4): 295-303, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31658862
6.
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.
Commun Chem
; 7(1): 38, 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378740
7.
Sulfonoketenimides as key intermediates for the synthesis of 2-thioxo-2H-1,3-thiazines and 2-arylimino-2H-1,3-thiazines.
Mol Divers
; 17(4): 801-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24052198
8.
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitors.
Methods Enzymol
; 685: 171-198, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245901
9.
Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library.
Eur J Pharmacol
; 938: 175395, 2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410418
10.
Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting properties.
Sci Rep
; 13(1): 14685, 2023 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37673888
11.
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.
Res Sq
; 2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37790373
12.
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors.
Front Chem
; 10: 969559, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36465863
13.
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives.
Eur J Pharmacol
; 894: 173850, 2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428899
14.
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met.
Sci Rep
; 11(1): 3644, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574356
15.
Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery Study.
Comb Chem High Throughput Screen
; 22(9): 635-648, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31696808
Resultados
1 -
15
de 15
1
Próxima >
>>